SPOP and posterior cortical atrophy: 1794 patients with metastatic PCa were divided into no TP53 and SPOP mutation cohort, TP53 mutation cohort, SPOP mutation cohort, and TP53 and SPOP co-mutation cohort according to their TP53 and SPOP mutation status (Figure 7A).